Prognosis of Neutrophil-To-Lymphocyte Ratio in Clinical Early-Stage Tongue (cT1/T2N0) Cancer

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s140800
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Prognostic Role for Derived Neutrophil-To-Lymphocyte Ratio in Early Breast Cancer

Annals of Oncology
MedicineOncologyHematology
2016English

Elective Neck Dissection Versus Observation in Early‐Stage (cT1/T2N0) Oral Squamous Cell Carcinoma

Laryngoscope Investigative Otolaryngology
2019English

Neutrophil-To-Lymphocyte Ratio and Prognosis of Spontaneous Intracerebral Hemorrhage

Turk Beyin Damar Hastaliklar Dergisi
NeurologyCardiovascular MedicineCardiology
2019English

Preoperative Platelet-To-Lymphocyte Ratio and Neutrophil-To-Lymphocyte Ratio as Predictors of Clinical Outcome in Patients With Gallbladder Cancer

Scientific Reports
Multidisciplinary
2019English

Pre-Treatment Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio Are Prognostic of Progression in Early Stage Classical Hodgkin Lymphoma

British Journal of Haematology
Hematology
2017English

Neutrophil to Lymphocyte Ratio in Allergic Rhinitis

European Archives of Oto-Rhino-Laryngology
MedicineOtorhinolaryngology
2016English

Evaluation of Mean Platelet Volume, Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Advanced Stage Endometriosis With Endometrioma

Journal of the Turkish German Gynecology Association
GynecologyObstetrics
2013English

Exploring the Prognostic Value of the Neutrophil-To-Lymphocyte Ratio in Cancer

Scientific Reports
Multidisciplinary
2019English

Clinical Significance of Neutrophil-To-Lymphocyte Ratio as a Predictor of Lymph Node Metastasis in Gastric Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy